MEAT (Most Economically Advantageous Tendering) - Ensuring Recognition for the Value of Innovation BELEN MARTI - Iberia Market Access CRISTINA NUNES - Market Access & Health Economics – LATAM Toronto Oct 17th 2017
Situation “New” European Policy on Public Procurement: Concept of purchasing considering Most Economically Advantageous Tendering and Value. Medtech Europe is partnering with Purchasing and Hospital/Regional stakeholders. Edwards BUs and cross functional teams: WG to understand and best shape and influence the evolution of MEAT. THV - Nathan Petersen; HVT - Jacky Amar; CC - Olga Quejido; Legal - Ennio Marengo; B&T - Martin Nozicka; MA - Gordon Goodall & Belén Martí
Value Based Healthcare & Value Based procurement Outcome Cost HC Value = Socio-economic impact Innovation Sustainability Patient HCP Health system Provider Outcomes Costs incl. care delivery Central goal in health care becomes value for the patient *M. Porter: Redefining Health Care, 2006 *"Redefining Healthcare", BCG analysis
Actions Current status of the EU Directive and MEAT. Experimenter’s feedback in countries piloting the tool (TAVI – H Clinic, SP). Session HC employees and consulting firms.
Results Educate key stakeholders at Edwards EMEA: New directive and potential opportunity. Adoption of the Value of Medical Technology is spreading worldwide.
Ensuring Value of Innovation Policies “allowing” adoption of Value Opportunities and barriers Definition Value of our technologies are adequately assessed.
Cross Geography Situation: MEAT application: Brazilian payer There are not reimbursement in the most Latin America countries for some EDW products The payers have a little knowledge about health economics GAP between the prices (EDW vs Competitors) MEAT application: Brazilian payer Health Plan with own hospitals Argentina Payer focused in elderly Mexico with Integrator Companies that sell the procedure package Colombia Payers that choice the hospitals by the package VALUE